Epalrestat Tablets ER (150mg)

Epstate ER 150 
Epalrestat Tablets ER (150mg) is used to treat diabetic nerve pain. Poorly controlled diabetes can eventually lead to diabetic nerve disease (neuropathy) as a complication. Epalrestat 150 mg medicine helps to relieve symptoms like burning pain and numbness seen in people with diabetic nerve disease.
Epalrestat Tablets ER belongs to a group of medicines known as Aldose reductase inhibitors. Epalrestat 150 Tablets  can be taken with or without food but you should try to take it at the same time every day. Epalrestat Tablets will help you to remember to take it. The dose and how often you need it will be decided by your doctor so that you get the right amount to control your symptoms. It may take up to 3 months to get the full benefits of this medicine, but you should keep taking it regularly.  Do not stop taking it without asking your doctor, otherwise, your condition may worsen.
This medicine is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. You should also continue taking other medicines prescribed by your doctor for blood sugar control. Keeping your blood sugar levels under control will help this medication work better.
 

Steris Healthcare Pvt. Ltd is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. 

For further information please contact:
info@sterispharma.com